Zacks Research Lowers Earnings Estimates for DENTSPLY SIRONA

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) – Zacks Research reduced their Q1 2025 earnings per share (EPS) estimates for shares of DENTSPLY SIRONA in a note issued to investors on Thursday, March 20th. Zacks Research analyst I. Bandyopadhyay now anticipates that the medical instruments supplier will post earnings of $0.31 per share for the quarter, down from their previous forecast of $0.42. The consensus estimate for DENTSPLY SIRONA’s current full-year earnings is $1.84 per share. Zacks Research also issued estimates for DENTSPLY SIRONA’s Q2 2025 earnings at $0.45 EPS, Q3 2025 earnings at $0.49 EPS, Q4 2025 earnings at $0.56 EPS, FY2025 earnings at $1.81 EPS, Q1 2026 earnings at $0.34 EPS, Q2 2026 earnings at $0.48 EPS, Q3 2026 earnings at $0.49 EPS, Q4 2026 earnings at $0.58 EPS, FY2026 earnings at $1.89 EPS and FY2027 earnings at $2.19 EPS.

A number of other analysts have also weighed in on the company. UBS Group lowered their target price on DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating for the company in a research note on Tuesday, December 3rd. Barrington Research lowered their price objective on shares of DENTSPLY SIRONA from $24.00 to $20.00 and set an “outperform” rating for the company in a research report on Friday, February 28th. Wells Fargo & Company dropped their target price on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an “equal weight” rating for the company in a research note on Friday, February 28th. Evercore ISI reissued an “in-line” rating and set a $20.00 price target on shares of DENTSPLY SIRONA in a research note on Tuesday, January 7th. Finally, StockNews.com lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Friday, February 28th. Twelve analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $23.33.

DENTSPLY SIRONA Trading Up 1.5 %

XRAY stock opened at $15.80 on Monday. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The stock has a market capitalization of $3.14 billion, a price-to-earnings ratio of -7.63, a P/E/G ratio of 1.80 and a beta of 0.98. The business has a fifty day moving average price of $17.86 and a 200 day moving average price of $20.40. DENTSPLY SIRONA has a fifty-two week low of $14.78 and a fifty-two week high of $33.42.

Institutional Investors Weigh In On DENTSPLY SIRONA

Several large investors have recently made changes to their positions in the stock. Vanguard Group Inc. raised its position in DENTSPLY SIRONA by 0.3% in the 4th quarter. Vanguard Group Inc. now owns 20,183,260 shares of the medical instruments supplier’s stock valued at $383,078,000 after buying an additional 65,478 shares during the last quarter. First Eagle Investment Management LLC grew its stake in shares of DENTSPLY SIRONA by 2.5% during the 4th quarter. First Eagle Investment Management LLC now owns 14,500,409 shares of the medical instruments supplier’s stock worth $275,218,000 after acquiring an additional 348,532 shares in the last quarter. Nuance Investments LLC raised its holdings in shares of DENTSPLY SIRONA by 25.0% in the fourth quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier’s stock valued at $257,103,000 after purchasing an additional 2,708,097 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its position in shares of DENTSPLY SIRONA by 18.7% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 12,549,242 shares of the medical instruments supplier’s stock worth $238,186,000 after purchasing an additional 1,975,404 shares in the last quarter. Finally, Fuller & Thaler Asset Management Inc. boosted its holdings in DENTSPLY SIRONA by 2.8% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 11,539,418 shares of the medical instruments supplier’s stock worth $219,018,000 after purchasing an additional 314,343 shares during the last quarter. Institutional investors own 95.70% of the company’s stock.

Insider Activity at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier bought 15,142 shares of the company’s stock in a transaction on Monday, March 3rd. The shares were purchased at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the acquisition, the director now owns 81,971 shares of the company’s stock, valued at approximately $1,353,341.21. This represents a 22.66 % increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. 0.52% of the stock is currently owned by corporate insiders.

DENTSPLY SIRONA Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 28th will be paid a $0.16 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.05%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -14.07%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.